On Monday, Geron Corp (NASDAQ: GERN) was 8.47% up from the session before settling in for the closing price of $1.18. A 52-week range for GERN has been $1.17 – $5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 6535.01% over the past five years. When this article was written, the company’s average yearly earnings per share was at 52.66%. With a float of $597.85 million, this company’s outstanding shares have now reached $636.92 million.
Let’s look at the performance matrix of the company that is accounted for 229 employees. In terms of profitability, gross margin is 97.97%, operating margin of -225.64%, and the pretax margin is -226.73%.
Geron Corp (GERN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Geron Corp stocks. The insider ownership of Geron Corp is 6.13%, while institutional ownership is 75.65%. The most recent insider transaction that took place on Feb 27 ’25, was worth 24,150. In this transaction EVP, Chief Legal Officer of this company bought 15,000 shares at a rate of $1.61, taking the stock ownership to the 26,682 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chairman, President and CEO bought 12,500 for $1.76, making the entire transaction worth $22,062. This insider now owns 12,500 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 52.66% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
You can see what Geron Corp (GERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Geron Corp (NASDAQ: GERN) saw its 5-day average volume 14.5 million, a positive change from its year-to-date volume of 14.2 million. As of the previous 9 days, the stock’s Stochastic %D was 14.60%. Additionally, its Average True Range was 0.12.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 3.89%, which indicates a significant decrease from 36.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.28% in the past 14 days, which was lower than the 87.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5018, while its 200-day Moving Average is $3.2709. Nevertheless, the first resistance level for the watch stands at $1.3333 in the near term. At $1.3867, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4383. If the price goes on to break the first support level at $1.2283, it is likely to go to the next support level at $1.1767. Assuming the price breaks the second support level, the third support level stands at $1.1233.
Geron Corp (NASDAQ: GERN) Key Stats
There are 636,918K outstanding shares of the company, which has a market capitalization of 815.25 million. As of now, sales total 76,990 K while income totals -174,570 K. Its latest quarter income was 47,540 K while its last quarter net income were -25,350 K.
